[1] Shao S, Kao T, Eckhaus J, et al. The association of percentage energy from fat and colon cancer risk among members of the US military[J].Eur J Cancer Prev,2015,24(3):188-194. [2] Klaver CEL, Musters GD, Bemelman WA, et al. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial[J].BMC Cancer,2015,15(1):103-108. [3] 刘万超,权文强,吴军录,等. 人血清外泌体癌胚抗原检测在结直肠癌诊断中的临床应用[J].中华检验医学杂志,2018,41(7):503-508. [4] 费丽娜,王一杉,高天翼,等. 术前外周血中性粒细胞和淋巴细胞比值在结直肠癌预后评价中的意义[J].中国微生态学杂志,2018,30(01):79-82. [5] 叶世富,周永祥,首峰,等.125I粒子植入治疗结肠癌肝转移患者的临床研究[J].癌症进展,2018,16(5):609-612. [6] Delong JC, Murakami T, Yazaki PJ, et al. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model[J].J Surg Res,2017,218(6):139-143. [7] 梁巍,胡雨薇,应媛媛. 联合检测D-二聚体、糖类抗原-199、癌胚抗原在结直肠癌患者中的临床价值[J].中国实验诊断学,2019,23(01):83-85. [8] 杨洁,王晨,徐庆春,等. 结直肠癌患者术前NLR、PLR、PDW与其预后的关系[J].山东医药,2018,58(24):61-63. [9] 覃罗,姚晖,徐亮. 中性粒细胞与淋巴细胞比值联合检测纤维蛋白原对结直肠癌预后的判断价值[J].中国免疫学杂志,2017,33(04):527-532. [10] 江慧洪,王晖,李阿建,等. 中性粒细胞/淋巴细胞比值对局部进展期结直肠癌患者预后的影响[J].中华胃肠外科杂志,2017,20(5):550-554. [11] 于倩倩,张明生,胡广原,等. 淋巴细胞与单核细胞和中性粒细胞之和的比值对转移性结直肠癌患者预后的预测价值[J].武汉大学学报(医学版),2016,37(5):772-776.
2020, Vol. 37 
